WALLACH DAVID has a total of 19 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COPENHAGEN UNIVERSITY, OSPREY PHARMACEUTICALS USA INC and THERAPTOSIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Canada | 8 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Enzymes | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Wallach David | 19 |
#2 | Kovalenko Andrei | 6 |
#3 | Engelmann Hartmut | 4 |
#4 | Aderka Dan | 4 |
#5 | Brakebusch Cord | 3 |
#6 | Mett Igor | 3 |
#7 | Ramakrishnan Parameswaran | 3 |
#8 | Beletsky Igor | 2 |
#9 | Appel Elena | 2 |
#10 | Kemper Oliver | 2 |
Publication | Filing date | Title |
---|---|---|
US7745579B1 | Inhibitor of NF-KB activation | |
CA2017025A1 | Tumor necrosis factor binding protein ii, its purification and antibodies thereto |